We have new resources to educate and promote 17P among eligible women and to inform healthcare providers about key information about this medication that has been shown to reduce the rate of recurring preterm delivery.
Our partners provide quality perinatal care to women across the state of North Carolina. We aim to continually strengthen and improve this collaboration. Check in with us to learn about upcoming meetings.
Our state continues to lead the nation in its commitment to reducing recurring preterm birth through the use of 17P. The NC 17P Project is working to make this treatment available to all eligible women.
Click Learn More to read our statement on the latest FDA trial of 17P.